Related Experiment Video
Updated: Mar 27, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
Published on: June 22, 2020
Relevance of truncating titin mutations in dilated cardiomyopathy
O Akinrinade1, T-P Alastalo1,2, J W Koskenvuo2,3
1Children's Hospital Helsinki, Pediatric Cardiology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Insights
Truncations in the titin (TTN) gene are a major cause of dilated cardiomyopathy (DCM). This study refines TTN variant assessment, revealing a high probability of pathogenicity for TTN-truncating variants (TTNtv) in DCM patients.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a genetic heart condition often caused by titin (TTN) gene truncations.
- Accurate assessment of TTN-truncating variants (TTNtv) and their population frequency is crucial for clinical interpretation.
Purpose of the Study:
- To refine the assessment strategy for TTNtv in DCM.
- To determine the prevalence and pathogenicity of TTNtv in DCM patients compared to the general population.
Main Methods:
- Aggregated TTNtv data from 1788 DCM patients and compared with over 60,000 individuals from the Exome Aggregation Consortium.
- Implemented a variant assessment strategy prioritizing TTNtv affecting all gene transcripts.
- Analyzed TTNtv enrichment in specific gene regions (A-band, I/A-band junction).
Main Results:
- TTNtv are significantly more prevalent in DCM patients than in the reference population (p = 4.1 × 10(-295)).
- TTNtv were enriched in the A-band and I/A-band junction of TTN.
- The probability of pathogenicity for TTNtv affecting all TTN transcripts in DCM patients was estimated at 97.8% (LR = 42.2).
Conclusions:
- TTNtv, particularly in the A-band region, carry a higher risk of causing DCM than previously thought.
- Prioritizing TTNtv affecting at least five TTN transcripts is recommended for improved DCM diagnosis and genetic counseling.
Abstract:
Dilated cardiomyopathy (DCM), a genetically heterogeneous cardiac disease characterized by left ventricular dilatation and systolic dysfunction, is caused majorly by truncations of titin (TTN), especially in A-band region. Clinical interpretation of TTN-truncating variants (TTNtv) has been challenged by the existing inaccurate variant assessment strategies and uncertainty in the true frequency of TTNtv across the general population. We aggregated TTNtv identified in 1788 DCM patients and compared the variants with those reported in over 60,000 Exome Aggregation Consortium reference population. We implemented our current variant assessment strategy that prioritizes TTNtv affecting all transcripts of the gene, and observed a decline in the prevalence of TTNtv in DCM. Despite this decline, TTNtv are more prevalent in DCM patients compared with reference population (p = 4.1 × 10(-295) ). Moreover, our extended analyses confirmed the enrichment of TTNtv not only in the A-band but also in the I/A-band junction of TTN. We estimated the probability of pathogenicity of TTNtv affecting all transcripts of TTN, identified in unselected DCM patients to be 97.8% (likelihood ratio (LR) = 42.2). We emphasize that identifying a TTNtv, especially in the A-band region, has a higher risk of being disease-causing than previously anticipated, and recommend prioritizing TTNtv affecting at least five transcripts of the gene.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy

